In PCa patients who have had their prostate removed, biochemical recurrence (BCR) of blood prostate-specific antigen (PSA) occurs in ~ 20–40% of cases within 10–15 years [4–6]. The gene discussed is KLK3; the disease is posterior cortical atrophy.